
Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients
The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread (metastasized) to …
READ MORE
Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients
The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread (metastasized) to …
READ MORE
Breaking News: FDA Approves Treatment for pNET Patients
For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients! The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients. This is a milestone for the carcinoid/NET…
READ MORE
All Things Zebra for Carcinoid and Neuroendocrine Tumor Awareness
At the Carcinoid Cancer Foundation we get many inquiries about where to purchase zebra-striped pins and other awareness items. We have scoured the Internet to share a wide variety of jewelry, party supplies, note cards, luggage, organizers, and everyday…
READ MORE
Carcinoid Cancer Foundation Thanks Symposium Sponsors
There’s still time to register for the Carcinoid Cancer Foundation’s 14th annual symposium for patients, family, friends, and healthcare professionals, which will be held on Sunday, May 1st at Mount Sinai Medical Center in New York City. The Foundation…
READ MORE
1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy (PRRNT)
Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin analogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to …
READ MORE
Multiple Endocrine Neoplasia (MEN) Seminar Scheduled for September 2011 at Mayo Clinic
SPECIAL NOTE: This seminar has been cancelled but may be rescheduled at a later date in a different format. We will post any updates we receive.
__________________________________________________________________
MEN, carcinoid, and neuroendocrine…
READ MORE
CNETS Canada Presents 2011 Halifax Neuroendocrine Conference for Patients and Medical Professionals
Carcinoid and neuroendocrine tumor patients and medical professionals are invited to attend the 2011 Halifax Conference, presented by the Canadian Neuroendocrine Tumour Society (CNETS). The conference will be held on Saturday, May 7 at the beautiful…
READ MORE
Carcinoid Cancer Foundation to Speak on Behalf of NET Cancer Patients at April 12, 2011 FDA Oncologic Drugs Advisory Committee Meeting
Grace Goldstein, Chief Operating Officer of the Carcinoid Cancer Foundation, will speak at the Open Public Hearing segment during the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee Meeting on April 12, 2011 in Silver …
READ MORE
Carcinoid Patient’s Stepdaughter Runs in Sun Trust National Marathon in Support of Carcinoid Cancer Foundation
If you are in Washington, D.C. on Saturday, March 26th cheer on Alex Todd-Lippock, bib number 3029, when she runs in the 2011 Sun Trust National Marathon in support of the Carcinoid Cancer Foundation (CCF). Ms. Todd-Lippock’s stepmother, Lisa Todd, is…
READ MORE